News Focus
News Focus
Followers 56
Posts 4233
Boards Moderated 0
Alias Born 03/20/2014

Re: Investor2014 post# 333076

Sunday, 10/17/2021 6:53:45 AM

Sunday, October 17, 2021 6:53:45 AM

Post# of 518941
What about Accelerated Approval with a surrogate endpoint?

Works like a charm these days.

Missling is waiting for trials and their data analysis to complete so that he has what is required to file an NDA should the results support it.

Like it or not, that is how it works.


Perhaps Anavex should be looking at the PET scans for Amyloid reduction?

Any port in a storm they say.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News